Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 1

Interventions

Specimen Handling 21Magnetic Resonance Spectroscopy 18Carboplatin 17Gemcitabine 15Cisplatin 12pembrolizumab 11Paclitaxel 11Injections 11Interviews as Topic 10fludarabine 9Radiotherapy 8Oxaliplatin 8Nivolumab 8Fluorouracil 8Dexamethasone 8Cyclophosphamide 8Irinotecan 7Bortezomib 7Biopsy 7Bevacizumab 7toripalimab 6Radiosurgery 6Pemetrexed 6Leucovorin 5Capecitabine 5130-nm albumin-bound paclitaxel 5trastuzumab deruxtecan 4liposomal doxorubicin 4cemiplimab 4X-Rays 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Nephrectomy × 30 days × Clear all
NCT07516366 2026-05-15

Testing the Safety and Feasibility of Immunotherapy Drugs, Botensilimab and Balstilimab, Before Surgery for Clear Cell Renal Cell Carcinoma, NEO RoBOT Trial

National Cancer Institute (NCI)

Phase 2 Not yet recruiting
16 enrolled
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡